{"gene":"DTX3","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2003,"finding":"DTX3 functions as an E3 ubiquitin-protein isopeptide ligase (E3), demonstrated by its capacity for self-ubiquitination in vitro. DTX family members including DTX3 homodimerize and heterodimerize in vivo, suggesting physical interactions between DTX family members modify E3 activity and/or substrate availability.","method":"In vitro self-ubiquitination assay, yeast two-hybrid, in vivo dimerization studies","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — direct in vitro E3 ligase activity demonstrated; foundational paper with >125 citations","pmids":["12670957"],"is_preprint":false},{"year":2020,"finding":"DTX3 promotes ubiquitination and degradation of NOTCH2, identified as a novel E3 ligase for NOTCH2. DTX3 overexpression suppressed proliferation, tumorigenicity, and colony formation of esophageal carcinoma cells, and DTX3 expression showed a significant negative correlation with NOTCH2 in patient tissue samples.","method":"Yeast two-hybrid screening for DTX3-NOTCH2 interaction, ubiquitination assay, gain/loss-of-function cell assays","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct ubiquitination assay and Y2H interaction, single lab","pmids":["31854042"],"is_preprint":false},{"year":2020,"finding":"DCAF13 binds the AU-rich element (ARE) in the 3'UTR of DTX3 mRNA to accelerate its degradation, acting as an RNA-binding protein that post-transcriptionally regulates DTX3. Loss of DTX3 (downstream of DCAF13) activates the NOTCH4 signaling pathway, as DTX3 promotes ubiquitination and degradation of NOTCH4.","method":"RNA-binding assay (ARE binding), mRNA stability assay, ubiquitination assay, gain/loss-of-function cell migration/invasion assays","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple functional assays demonstrating DTX3 ubiquitinates NOTCH4 and DCAF13 controls DTX3 mRNA; single lab","pmids":["33300431"],"is_preprint":false},{"year":2020,"finding":"DTX3 mediates ubiquitination and stabilization of mutant p53 (not degradation) by perturbing the MDM2-mutant p53 interaction, thereby activating diverse mutant p53 target genes and promoting ovarian cancer cell proliferation and invasion.","method":"Co-immunoprecipitation, ubiquitination assay, gain/loss-of-function with gene expression analysis, in vivo tumor growth assay","journal":"Genes & diseases","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct ubiquitination assay and co-IP identifying mutant p53 as substrate; single lab, multiple methods","pmids":["35782979"],"is_preprint":false},{"year":2021,"finding":"DTX3 promotes ubiquitination of XRCC5 (Ku80) and co-localizes with XRCC5 in the nucleus. DTX3 overexpression inhibits EMT and AKT signaling in papillary thyroid carcinoma cells, and knockdown produces opposite effects.","method":"IP-mass spectrometry, co-immunoprecipitation, immunofluorescence co-localization, ubiquitination assay, gain/loss-of-function cell assays","journal":"Journal of Cancer","confidence":"Medium","confidence_rationale":"Tier 2-3 — IP-MS identified interactors, co-IP and ubiquitination assay confirmed XRCC5 as substrate; single lab with multiple orthogonal methods","pmids":["33403043"],"is_preprint":false},{"year":2024,"finding":"DTX3 (like DTX3L) can directly ubiquitylate DNA and RNA in vitro via ester bond formation, a non-proteinaceous substrate activity not shared by DTX1, DTX2, or DTX4. DTX3L shows preference for the 3'-terminal adenosine. This nucleic acid ubiquitylation is reversible by DUBs USP2, JOSD1, and SARS-CoV-2 PLpro.","method":"In vitro ubiquitylation assay with purified proteins, biochemical characterization of ester bond formation, DUB reversal assay","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with purified proteins, activity mapped to specific family members, reversibility demonstrated","pmids":["39242775"],"is_preprint":false},{"year":2023,"finding":"A novel N-terminal isoform of DTX3 (DTX3c) forms an E3 ubiquitin ligase complex with UBA1 (E1), UBE2N (E2), and the ATPase/unfoldase Cdc48/p97 that promotes degradation of EphB4 angiogenic kinase upon autocrine IGF-II signal deprivation in malignant mesothelioma cells. Cdc48/p97 ATPase activity is required for EphB4 recruitment to the complex.","method":"Targeted proteomics, co-immunoprecipitation, PCR cloning, 3D structural modeling, functional perturbation of Cdc48/p97 ATPase activity","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2-3 — reciprocal co-IP and targeted proteomics identifying complex members, functional perturbation of Cdc48/p97; single lab","pmids":["37108544"],"is_preprint":false},{"year":2022,"finding":"DTX3 regulates colorectal cancer cell growth and cell cycle progression by modulating the transcriptional activity of E2F1 and its downstream targets CDC2 and Cyclin D3. DTX3 overexpression reduces E2F1 transcriptional activity, while DTX3 knockout increases it.","method":"Gain/loss-of-function (overexpression, knockout), colony formation assay, proliferation assay, E2F1 transcriptional activity measurement, Western blot for CDC2/Cyclin D3","journal":"Molecular biology reports","confidence":"Low","confidence_rationale":"Tier 3 — defined cellular phenotype with pathway placement but no direct biochemical evidence of DTX3-E2F1 interaction; single lab","pmids":["35098394"],"is_preprint":false},{"year":2025,"finding":"DTX3 binds to the Notch intracellular domain (NICD) via its C-terminal RING finger domain (RFD), ubiquitinates NICD, and promotes its degradation, thereby suppressing Notch signaling pathway activity and inhibiting bladder cancer cell invasion and EMT. Notch signaling inhibitor DAPT partially reverses the effects of DTX3 knockdown.","method":"Co-immunoprecipitation (DTX3-NICD), domain mapping (RFD), ubiquitination assay, gain/loss-of-function with migration/invasion assays in vitro and in vivo, epistasis with DAPT","journal":"International immunopharmacology","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct co-IP and ubiquitination assay identifying NICD as substrate and RFD as binding domain, epistasis with pathway inhibitor; single lab","pmids":["40127622"],"is_preprint":false},{"year":2025,"finding":"DTX3 catalyzes monoubiquitylation of tankyrase on mono-ADP-ribose (MAR) rather than on a canonical lysine, creating a monoubiquitin-MAR hybrid mark. This ubiquitylation near the ADP-ribose addition site prevents PAR formation by tankyrase, antagonizing the PAR-binding E3 ligase RNF146 and thereby stabilizing tankyrase. The hybrid mark is then recognized by RING-UIM E3 ligases RNF114 and RNF166.","method":"Cell-based ubiquitylation assay, biochemical characterization of ubiquitin-MAR hybrid mark, identification of reader domain in RNF114/RNF166","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — direct identification of non-canonical ubiquitylation on MAR, mechanistic epistasis with RNF146/RNF114/RNF166; preprint, single lab","pmids":["bio_10.1101_2025.04.09.648013"],"is_preprint":true},{"year":2025,"finding":"DTX3 inhibits CRC cell migration, invasion, and EMT through the AKT signaling pathway; overexpression reduces Vimentin and p-AKT protein levels and increases E-cadherin, while knockdown reverses these effects.","method":"Gain/loss-of-function (shRNA, overexpression), scratch assay, Transwell invasion assay, Western blot for EMT markers and p-AKT","journal":"Translational cancer research","confidence":"Low","confidence_rationale":"Tier 3 — defined cellular phenotype with pathway marker changes but no direct biochemical evidence of DTX3-AKT axis mechanism; single lab","pmids":["41158261"],"is_preprint":false}],"current_model":"DTX3 is a RING finger-domain E3 ubiquitin ligase that ubiquitylates both protein substrates (NOTCH2, NOTCH4, NICD, XRCC5, mutant p53, EphB4 via the DTX3c isoform, and tankyrase on ADP-ribose rather than lysine) and nucleic acids (DNA/RNA via ester bond), operates in Notch, AKT, p53, and EphB4 signaling pathways, and can form heteromeric complexes with other DTX family members and with UBA1/UBE2N/Cdc48-p97 to regulate substrate degradation or stabilization in a context-dependent manner."},"narrative":{"teleology":[{"year":2003,"claim":"Establishing DTX3 as an E3 ubiquitin ligase resolved whether DTX-family proteins possess intrinsic catalytic activity beyond their known role as Notch-pathway modulators in Drosophila.","evidence":"In vitro self-ubiquitination assay with purified DTX3 plus yeast two-hybrid and in vivo dimerization studies demonstrating homo- and heterodimerization among DTX family members","pmids":["12670957"],"confidence":"High","gaps":["No physiological substrates identified at this stage","Functional consequence of DTX homo-/heterodimerization on substrate selection or E3 activity undefined","In vivo relevance of DTX3 E3 activity not tested"]},{"year":2020,"claim":"Identification of NOTCH2 and NOTCH4 as direct ubiquitylation substrates established DTX3 as a negative regulator of Notch signaling through receptor degradation, answering whether DTX3 has physiological substrates.","evidence":"Yeast two-hybrid screen for DTX3-NOTCH2 interaction, ubiquitination assays, and gain/loss-of-function proliferation assays in esophageal carcinoma cells (NOTCH2); ARE-binding/mRNA stability assays showing DCAF13 controls DTX3 mRNA, plus ubiquitination assays confirming DTX3 targets NOTCH4 for degradation","pmids":["31854042","33300431"],"confidence":"Medium","gaps":["NOTCH2 and NOTCH4 ubiquitylation studies each from single labs; independent replication lacking","Ubiquitin chain type and specific lysine sites on NOTCH2/NOTCH4 not mapped","Whether DTX3 acts on full-length receptors at the membrane versus cleaved intracellular domain not resolved at this point"]},{"year":2020,"claim":"Discovery that DTX3 ubiquitinates mutant p53 to stabilize rather than degrade it revealed context-dependent outcomes of DTX3-mediated ubiquitylation, expanding its substrate repertoire beyond Notch receptors.","evidence":"Co-immunoprecipitation and ubiquitination assays in ovarian cancer cells showing DTX3 disrupts MDM2-mutant p53 interaction and stabilizes mutant p53, with in vivo tumor growth validation","pmids":["35782979"],"confidence":"Medium","gaps":["Mechanism distinguishing DTX3-mediated stabilizing versus degradative ubiquitylation not elucidated","Ubiquitin chain linkage type on mutant p53 not determined","Single lab; not independently confirmed"]},{"year":2021,"claim":"Identification of XRCC5/Ku80 as a DTX3 substrate linked DTX3 to DNA repair protein turnover and AKT signaling suppression, broadening its functional scope beyond Notch.","evidence":"IP-mass spectrometry, co-IP, immunofluorescence co-localization in the nucleus, and ubiquitination assays in papillary thyroid carcinoma cells","pmids":["33403043"],"confidence":"Medium","gaps":["Whether DTX3-mediated XRCC5 ubiquitylation affects DNA repair function not tested","Mechanism linking XRCC5 ubiquitylation to AKT pathway suppression unclear","Single lab with no structural or in vivo validation"]},{"year":2023,"claim":"Discovery of the DTX3c isoform and its assembly into a UBA1/UBE2N/Cdc48-p97 complex targeting EphB4 revealed isoform-specific complex formation and a mechanism coupling substrate recruitment to AAA-ATPase unfoldase activity.","evidence":"Targeted proteomics and reciprocal co-IP in malignant mesothelioma cells identifying complex members, plus functional perturbation of Cdc48/p97 ATPase activity","pmids":["37108544"],"confidence":"Medium","gaps":["Only one cell system (mesothelioma) tested; generality of the DTX3c complex unknown","Direct in vitro reconstitution of the DTX3c-Cdc48/p97 complex not performed","Ubiquitin chain type on EphB4 and degradation pathway (proteasomal vs. lysosomal) not determined"]},{"year":2024,"claim":"Demonstration that DTX3 ubiquitylates DNA and RNA via ester bonds established a fundamentally non-canonical catalytic activity, revealing DTX3 can act on nucleic acid substrates like DTX3L.","evidence":"Reconstituted in vitro ubiquitylation assays with purified proteins, ester bond characterization, and DUB reversal by USP2, JOSD1, and SARS-CoV-2 PLpro","pmids":["39242775"],"confidence":"High","gaps":["Physiological function of nucleic acid ubiquitylation by DTX3 in cells not demonstrated","Whether DTX3 and DTX3L have redundant or distinct nucleic acid substrates in vivo unknown","Structural basis for DTX3 preference among nucleic acid substrates not resolved"]},{"year":2025,"claim":"Mapping the DTX3-NICD interaction to the RING finger domain and demonstrating NICD ubiquitylation/degradation with epistasis via Notch inhibitor DAPT resolved how DTX3 directly suppresses Notch transcriptional output at the level of the active signaling fragment.","evidence":"Co-IP with domain truncation mapping, ubiquitination assay, and rescue with DAPT in bladder cancer cells in vitro and in vivo","pmids":["40127622"],"confidence":"Medium","gaps":["Whether NICD ubiquitylation is the dominant mechanism across all tissue contexts or overlaps with NOTCH2/4 full-length receptor targeting is unresolved","Single lab study; independent confirmation needed"]},{"year":2025,"claim":"Discovery that DTX3 monoubiquitylates tankyrase on mono-ADP-ribose (not lysine) introduced a novel non-canonical ubiquitylation modality — a ubiquitin-MAR hybrid mark — that antagonizes PARylation and stabilizes tankyrase by blocking RNF146-dependent degradation. (preprint)","evidence":"Cell-based ubiquitylation assays and biochemical characterization of ubiquitin-MAR hybrid mark; identification of RNF114/RNF166 as hybrid-mark readers (preprint)","pmids":["bio_10.1101_2025.04.09.648013"],"confidence":"Medium","gaps":["Preprint; not yet peer-reviewed","In vivo significance of the ubiquitin-MAR hybrid mark for Wnt signaling or other tankyrase-dependent pathways not tested","Structural basis for DTX3 recognition of the MAR moiety not determined"]},{"year":null,"claim":"The rules governing whether DTX3 ubiquitylation leads to substrate degradation versus stabilization, and the physiological significance of its nucleic acid and ADP-ribose ubiquitylation activities, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of DTX3 or DTX3-substrate complexes exists","Chain-type specificity (K48, K63, mono-Ub) dictating substrate fate not systematically characterized","In vivo mouse knockout or genetic model for DTX3 has not been reported","Relative contributions of canonical protein versus non-canonical nucleic acid/MAR ubiquitylation to DTX3 physiological function unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,2,3,4,5,6,8,9]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0,1,2,3,4,8]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,2,8]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,2,3,4,6,8,9]}],"complexes":["DTX homo/heterodimer complex","DTX3c-UBA1-UBE2N-Cdc48/p97 complex"],"partners":["NOTCH2","NOTCH4","XRCC5","UBA1","UBE2N","VCP","EPHB4","TP53"],"other_free_text":[]},"mechanistic_narrative":"DTX3 is a RING finger-domain E3 ubiquitin ligase that negatively regulates Notch signaling and modulates diverse substrates through both canonical and non-canonical ubiquitylation. DTX3 ubiquitinates and promotes proteasomal degradation of NOTCH2, NOTCH4, and the Notch intracellular domain (NICD) via its C-terminal RING finger domain, suppressing Notch-dependent transcription, EMT, and tumor cell invasion [PMID:31854042, PMID:33300431, PMID:40127622]. Beyond canonical protein substrates such as XRCC5 and mutant p53, DTX3 catalyzes ubiquitylation of nucleic acids (DNA and RNA) through ester bond formation and can monoubiquitylate tankyrase on mono-ADP-ribose rather than lysine, creating a hybrid ubiquitin-MAR mark that antagonizes PARylation-dependent degradation [PMID:39242775, PMID:35782979, PMID:33403043]. DTX3 homodimerizes and heterodimerizes with other DTX family members, and a distinct N-terminal isoform (DTX3c) assembles with UBA1, UBE2N, and the Cdc48/p97 ATPase to target the EphB4 receptor kinase for degradation [PMID:12670957, PMID:37108544]."},"prefetch_data":{"uniprot":{"accession":"Q8N9I9","full_name":"E3 ubiquitin-protein ligase DTX3","aliases":["Protein deltex-3","Deltex3","RING finger protein 154","RING-type E3 ubiquitin transferase DTX3"],"length_aa":347,"mass_kda":38.0,"function":"Functions as an ubiquitin ligase protein, and regulates Notch signaling (PubMed:35782979, PubMed:40127622). By promoting the ubiquitination and subsequent degradation of target proteins, it can block activation of the Notch signaling pathway, potentially acting as a tumor suppressor in human cancers (PubMed:31854042, PubMed:35782979, PubMed:40127622) Involved in the angiogenic EPHB4 kinase degradation in cancer cell","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8N9I9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DTX3","classification":"Not Classified","n_dependent_lines":10,"n_total_lines":1208,"dependency_fraction":0.008278145695364239},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DTX3","total_profiled":1310},"omim":[{"mim_id":"613143","title":"DELTEX E3 UBIQUITIN LIGASE 3L; DTX3L","url":"https://www.omim.org/entry/613143"},{"mim_id":"613142","title":"DELTEX E3 UBIQUITIN LIGASE 3; DTX3","url":"https://www.omim.org/entry/613142"},{"mim_id":"613141","title":"DELTEX E3 UBIQUITIN LIGASE 2; DTX2","url":"https://www.omim.org/entry/613141"},{"mim_id":"605501","title":"M-PHASE PHOSPHOPROTEIN 9; MPHOSPH9","url":"https://www.omim.org/entry/605501"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nucleoli","reliability":"Approved"},{"location":"Golgi apparatus","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DTX3"},"hgnc":{"alias_symbol":["FLJ34766","RNF154"],"prev_symbol":[]},"alphafold":{"accession":"Q8N9I9","domains":[{"cath_id":"3.30.1370.10","chopping":"17-97","consensus_level":"high","plddt":86.5156,"start":17,"end":97},{"cath_id":"3.30.40.10","chopping":"162-207","consensus_level":"medium","plddt":89.902,"start":162,"end":207},{"cath_id":"3.30.390.130","chopping":"217-341","consensus_level":"high","plddt":95.2777,"start":217,"end":341}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N9I9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N9I9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8N9I9-F1-predicted_aligned_error_v6.png","plddt_mean":82.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DTX3","jax_strain_url":"https://www.jax.org/strain/search?query=DTX3"},"sequence":{"accession":"Q8N9I9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8N9I9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8N9I9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8N9I9"}},"corpus_meta":[{"pmid":"25151356","id":"PMC_25151356","title":"An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer.","date":"2014","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25151356","citation_count":211,"is_preprint":false},{"pmid":"12670957","id":"PMC_12670957","title":"The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activity.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12670957","citation_count":125,"is_preprint":false},{"pmid":"20122155","id":"PMC_20122155","title":"Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer.","date":"2010","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20122155","citation_count":70,"is_preprint":false},{"pmid":"34513839","id":"PMC_34513839","title":"Functions and Molecular Mechanisms of Deltex Family Ubiquitin E3 Ligases in Development and Disease.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34513839","citation_count":42,"is_preprint":false},{"pmid":"16404137","id":"PMC_16404137","title":"Metabolic transformation of dinophysistoxin-3 into dinophysistoxin-1 causes human intoxication by consumption of O-acyl-derivatives dinophysistoxins contaminated shellfish.","date":"2005","source":"The Journal of toxicological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16404137","citation_count":40,"is_preprint":false},{"pmid":"31672229","id":"PMC_31672229","title":"Multi-species okadaic acid contamination and human poisoning during a massive bloom of Dinophysis acuminata complex in southern Brazil.","date":"2019","source":"Harmful algae","url":"https://pubmed.ncbi.nlm.nih.gov/31672229","citation_count":39,"is_preprint":false},{"pmid":"23434830","id":"PMC_23434830","title":"In vitro acylation of okadaic acid in the presence of various bivalves' extracts.","date":"2013","source":"Marine drugs","url":"https://pubmed.ncbi.nlm.nih.gov/23434830","citation_count":29,"is_preprint":false},{"pmid":"33300431","id":"PMC_33300431","title":"DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation.","date":"2020","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/33300431","citation_count":28,"is_preprint":false},{"pmid":"31854042","id":"PMC_31854042","title":"Ubiquitination of NOTCH2 by DTX3 suppresses the proliferation and migration of human esophageal carcinoma.","date":"2020","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/31854042","citation_count":27,"is_preprint":false},{"pmid":"33773701","id":"PMC_33773701","title":"Highly sensitive electrochemical detection of the marine toxins okadaic acid and domoic acid with carbon black modified screen printed electrodes.","date":"2021","source":"Talanta","url":"https://pubmed.ncbi.nlm.nih.gov/33773701","citation_count":27,"is_preprint":false},{"pmid":"39242775","id":"PMC_39242775","title":"Ubiquitylation of nucleic acids by DELTEX ubiquitin E3 ligase DTX3L.","date":"2024","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/39242775","citation_count":19,"is_preprint":false},{"pmid":"26633503","id":"PMC_26633503","title":"Assimilation, Accumulation, and Metabolism of Dinophysistoxins (DTXs) and Pectenotoxins (PTXs) in the Several Tissues of Japanese Scallop Patinopecten yessoensis.","date":"2015","source":"Toxins","url":"https://pubmed.ncbi.nlm.nih.gov/26633503","citation_count":19,"is_preprint":false},{"pmid":"22613166","id":"PMC_22613166","title":"Isolation and characterization of an enzyme from the Greenshell™ mussel Perna canaliculus that hydrolyses pectenotoxins and esters of okadaic acid.","date":"2012","source":"Toxicon : official journal of the International Society on Toxinology","url":"https://pubmed.ncbi.nlm.nih.gov/22613166","citation_count":17,"is_preprint":false},{"pmid":"33403043","id":"PMC_33403043","title":"Deltex3 inhibits Epithelial Mesenchymal Transition in Papillary Thyroid Carcinoma via promoting ubiquitination of XRCC5 to regulate the AKT signal pathway.","date":"2021","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33403043","citation_count":14,"is_preprint":false},{"pmid":"33987007","id":"PMC_33987007","title":"Identification of key genes and biological processes contributing to colitis associated dysplasia in ulcerative colitis.","date":"2021","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/33987007","citation_count":14,"is_preprint":false},{"pmid":"37443713","id":"PMC_37443713","title":"The DTX Protein Family: An Emerging Set of E3 Ubiquitin Ligases in Cancer.","date":"2023","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/37443713","citation_count":13,"is_preprint":false},{"pmid":"14513712","id":"PMC_14513712","title":"Quantitation of diarrhetic shellfish poisoning toxins in Chilean mussel using pyrenyldiazomethane as fluorescent labeling reagent.","date":"2003","source":"Biological research","url":"https://pubmed.ncbi.nlm.nih.gov/14513712","citation_count":11,"is_preprint":false},{"pmid":"20519842","id":"PMC_20519842","title":"First evidence of Okadaic acid acyl-derivative and Dinophysistoxin-3 in mussel samples collected in Chiloe Island, Southern Chile.","date":"2010","source":"The Journal of toxicological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/20519842","citation_count":10,"is_preprint":false},{"pmid":"35782979","id":"PMC_35782979","title":"Ubiquitin ligase DTX3 empowers mutant p53 to promote ovarian cancer development.","date":"2020","source":"Genes & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/35782979","citation_count":9,"is_preprint":false},{"pmid":"35974412","id":"PMC_35974412","title":"Genome-wide analysis of genes encoding core components of the ubiquitin system during cerebral cortex development.","date":"2022","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/35974412","citation_count":9,"is_preprint":false},{"pmid":"27231127","id":"PMC_27231127","title":"Effect of carbon chain length in acyl coenzyme A on the efficiency of enzymatic transformation of okadaic acid to 7-O-acyl okadaic acid.","date":"2016","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/27231127","citation_count":7,"is_preprint":false},{"pmid":"35098394","id":"PMC_35098394","title":"Deltex E3 ubiquitin ligase 3 inhibits colorectal cancer cell growth and regulates cell cycle progression via upregulating E2F transcription factor 1.","date":"2022","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/35098394","citation_count":6,"is_preprint":false},{"pmid":"39057646","id":"PMC_39057646","title":"The Role of NOTCH Pathway Genes in the Inherited Susceptibility to Aortic Stenosis.","date":"2024","source":"Journal of cardiovascular development and disease","url":"https://pubmed.ncbi.nlm.nih.gov/39057646","citation_count":5,"is_preprint":false},{"pmid":"37108544","id":"PMC_37108544","title":"Novel Isoform DTX3c Associates with UBE2N-UBA1 and Cdc48/p97 as Part of the EphB4 Degradation Complex Regulated by the Autocrine IGF-II/IRA Signal in Malignant Mesothelioma.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37108544","citation_count":5,"is_preprint":false},{"pmid":"34163522","id":"PMC_34163522","title":"Identifying Key Somatic Copy Number Alterations Driving Dysregulation of Cancer Hallmarks in Lower-Grade Glioma.","date":"2021","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34163522","citation_count":5,"is_preprint":false},{"pmid":"40127622","id":"PMC_40127622","title":"DTX3 suppresses bladder cancer cell invasion and metastasis by inhibiting the Notch signaling pathway.","date":"2025","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40127622","citation_count":3,"is_preprint":false},{"pmid":"38890657","id":"PMC_38890657","title":"Autophagy-related molecular clusters identified as indicators for distinguishing active and latent TB infection in pediatric patients.","date":"2024","source":"BMC pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/38890657","citation_count":3,"is_preprint":false},{"pmid":"38886126","id":"PMC_38886126","title":"Assay for okadaic acid O-acyl transferase using HPLC-FLD.","date":"2024","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38886126","citation_count":1,"is_preprint":false},{"pmid":"41158261","id":"PMC_41158261","title":"DTX3 inhibits cell migration, invasion, and epithelial-mesenchymal transition in colorectal cancer through the AKT signaling pathway.","date":"2025","source":"Translational cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/41158261","citation_count":0,"is_preprint":false},{"pmid":"40715324","id":"PMC_40715324","title":"Hepatocyte reporter cells and integrated metabolomic and transcriptomic analyses reveal insights into hepatocyte changes in offspring of pregnancies with obesity.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40715324","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.09.648013","title":"Deltex and RING-UIM E3 ligases cooperate to create a ubiquitin-ADP-ribose hybrid mark on tankyrase, promoting its stabilization","date":"2025-04-09","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.09.648013","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":17742,"output_tokens":2881,"usd":0.04822},"stage2":{"model":"claude-opus-4-6","input_tokens":6205,"output_tokens":2902,"usd":0.155362},"total_usd":0.203582,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"DTX3 functions as an E3 ubiquitin-protein isopeptide ligase (E3), demonstrated by its capacity for self-ubiquitination in vitro. DTX family members including DTX3 homodimerize and heterodimerize in vivo, suggesting physical interactions between DTX family members modify E3 activity and/or substrate availability.\",\n      \"method\": \"In vitro self-ubiquitination assay, yeast two-hybrid, in vivo dimerization studies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct in vitro E3 ligase activity demonstrated; foundational paper with >125 citations\",\n      \"pmids\": [\"12670957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DTX3 promotes ubiquitination and degradation of NOTCH2, identified as a novel E3 ligase for NOTCH2. DTX3 overexpression suppressed proliferation, tumorigenicity, and colony formation of esophageal carcinoma cells, and DTX3 expression showed a significant negative correlation with NOTCH2 in patient tissue samples.\",\n      \"method\": \"Yeast two-hybrid screening for DTX3-NOTCH2 interaction, ubiquitination assay, gain/loss-of-function cell assays\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct ubiquitination assay and Y2H interaction, single lab\",\n      \"pmids\": [\"31854042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DCAF13 binds the AU-rich element (ARE) in the 3'UTR of DTX3 mRNA to accelerate its degradation, acting as an RNA-binding protein that post-transcriptionally regulates DTX3. Loss of DTX3 (downstream of DCAF13) activates the NOTCH4 signaling pathway, as DTX3 promotes ubiquitination and degradation of NOTCH4.\",\n      \"method\": \"RNA-binding assay (ARE binding), mRNA stability assay, ubiquitination assay, gain/loss-of-function cell migration/invasion assays\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple functional assays demonstrating DTX3 ubiquitinates NOTCH4 and DCAF13 controls DTX3 mRNA; single lab\",\n      \"pmids\": [\"33300431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DTX3 mediates ubiquitination and stabilization of mutant p53 (not degradation) by perturbing the MDM2-mutant p53 interaction, thereby activating diverse mutant p53 target genes and promoting ovarian cancer cell proliferation and invasion.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, gain/loss-of-function with gene expression analysis, in vivo tumor growth assay\",\n      \"journal\": \"Genes & diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct ubiquitination assay and co-IP identifying mutant p53 as substrate; single lab, multiple methods\",\n      \"pmids\": [\"35782979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DTX3 promotes ubiquitination of XRCC5 (Ku80) and co-localizes with XRCC5 in the nucleus. DTX3 overexpression inhibits EMT and AKT signaling in papillary thyroid carcinoma cells, and knockdown produces opposite effects.\",\n      \"method\": \"IP-mass spectrometry, co-immunoprecipitation, immunofluorescence co-localization, ubiquitination assay, gain/loss-of-function cell assays\",\n      \"journal\": \"Journal of Cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — IP-MS identified interactors, co-IP and ubiquitination assay confirmed XRCC5 as substrate; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"33403043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DTX3 (like DTX3L) can directly ubiquitylate DNA and RNA in vitro via ester bond formation, a non-proteinaceous substrate activity not shared by DTX1, DTX2, or DTX4. DTX3L shows preference for the 3'-terminal adenosine. This nucleic acid ubiquitylation is reversible by DUBs USP2, JOSD1, and SARS-CoV-2 PLpro.\",\n      \"method\": \"In vitro ubiquitylation assay with purified proteins, biochemical characterization of ester bond formation, DUB reversal assay\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with purified proteins, activity mapped to specific family members, reversibility demonstrated\",\n      \"pmids\": [\"39242775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"A novel N-terminal isoform of DTX3 (DTX3c) forms an E3 ubiquitin ligase complex with UBA1 (E1), UBE2N (E2), and the ATPase/unfoldase Cdc48/p97 that promotes degradation of EphB4 angiogenic kinase upon autocrine IGF-II signal deprivation in malignant mesothelioma cells. Cdc48/p97 ATPase activity is required for EphB4 recruitment to the complex.\",\n      \"method\": \"Targeted proteomics, co-immunoprecipitation, PCR cloning, 3D structural modeling, functional perturbation of Cdc48/p97 ATPase activity\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — reciprocal co-IP and targeted proteomics identifying complex members, functional perturbation of Cdc48/p97; single lab\",\n      \"pmids\": [\"37108544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"DTX3 regulates colorectal cancer cell growth and cell cycle progression by modulating the transcriptional activity of E2F1 and its downstream targets CDC2 and Cyclin D3. DTX3 overexpression reduces E2F1 transcriptional activity, while DTX3 knockout increases it.\",\n      \"method\": \"Gain/loss-of-function (overexpression, knockout), colony formation assay, proliferation assay, E2F1 transcriptional activity measurement, Western blot for CDC2/Cyclin D3\",\n      \"journal\": \"Molecular biology reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — defined cellular phenotype with pathway placement but no direct biochemical evidence of DTX3-E2F1 interaction; single lab\",\n      \"pmids\": [\"35098394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DTX3 binds to the Notch intracellular domain (NICD) via its C-terminal RING finger domain (RFD), ubiquitinates NICD, and promotes its degradation, thereby suppressing Notch signaling pathway activity and inhibiting bladder cancer cell invasion and EMT. Notch signaling inhibitor DAPT partially reverses the effects of DTX3 knockdown.\",\n      \"method\": \"Co-immunoprecipitation (DTX3-NICD), domain mapping (RFD), ubiquitination assay, gain/loss-of-function with migration/invasion assays in vitro and in vivo, epistasis with DAPT\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct co-IP and ubiquitination assay identifying NICD as substrate and RFD as binding domain, epistasis with pathway inhibitor; single lab\",\n      \"pmids\": [\"40127622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DTX3 catalyzes monoubiquitylation of tankyrase on mono-ADP-ribose (MAR) rather than on a canonical lysine, creating a monoubiquitin-MAR hybrid mark. This ubiquitylation near the ADP-ribose addition site prevents PAR formation by tankyrase, antagonizing the PAR-binding E3 ligase RNF146 and thereby stabilizing tankyrase. The hybrid mark is then recognized by RING-UIM E3 ligases RNF114 and RNF166.\",\n      \"method\": \"Cell-based ubiquitylation assay, biochemical characterization of ubiquitin-MAR hybrid mark, identification of reader domain in RNF114/RNF166\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct identification of non-canonical ubiquitylation on MAR, mechanistic epistasis with RNF146/RNF114/RNF166; preprint, single lab\",\n      \"pmids\": [\"bio_10.1101_2025.04.09.648013\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DTX3 inhibits CRC cell migration, invasion, and EMT through the AKT signaling pathway; overexpression reduces Vimentin and p-AKT protein levels and increases E-cadherin, while knockdown reverses these effects.\",\n      \"method\": \"Gain/loss-of-function (shRNA, overexpression), scratch assay, Transwell invasion assay, Western blot for EMT markers and p-AKT\",\n      \"journal\": \"Translational cancer research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — defined cellular phenotype with pathway marker changes but no direct biochemical evidence of DTX3-AKT axis mechanism; single lab\",\n      \"pmids\": [\"41158261\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DTX3 is a RING finger-domain E3 ubiquitin ligase that ubiquitylates both protein substrates (NOTCH2, NOTCH4, NICD, XRCC5, mutant p53, EphB4 via the DTX3c isoform, and tankyrase on ADP-ribose rather than lysine) and nucleic acids (DNA/RNA via ester bond), operates in Notch, AKT, p53, and EphB4 signaling pathways, and can form heteromeric complexes with other DTX family members and with UBA1/UBE2N/Cdc48-p97 to regulate substrate degradation or stabilization in a context-dependent manner.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DTX3 is a RING finger-domain E3 ubiquitin ligase that negatively regulates Notch signaling and modulates diverse substrates through both canonical and non-canonical ubiquitylation. DTX3 ubiquitinates and promotes proteasomal degradation of NOTCH2, NOTCH4, and the Notch intracellular domain (NICD) via its C-terminal RING finger domain, suppressing Notch-dependent transcription, EMT, and tumor cell invasion [PMID:31854042, PMID:33300431, PMID:40127622]. Beyond canonical protein substrates such as XRCC5 and mutant p53, DTX3 catalyzes ubiquitylation of nucleic acids (DNA and RNA) through ester bond formation and can monoubiquitylate tankyrase on mono-ADP-ribose rather than lysine, creating a hybrid ubiquitin-MAR mark that antagonizes PARylation-dependent degradation [PMID:39242775, PMID:35782979, PMID:33403043]. DTX3 homodimerizes and heterodimerizes with other DTX family members, and a distinct N-terminal isoform (DTX3c) assembles with UBA1, UBE2N, and the Cdc48/p97 ATPase to target the EphB4 receptor kinase for degradation [PMID:12670957, PMID:37108544].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing DTX3 as an E3 ubiquitin ligase resolved whether DTX-family proteins possess intrinsic catalytic activity beyond their known role as Notch-pathway modulators in Drosophila.\",\n      \"evidence\": \"In vitro self-ubiquitination assay with purified DTX3 plus yeast two-hybrid and in vivo dimerization studies demonstrating homo- and heterodimerization among DTX family members\",\n      \"pmids\": [\"12670957\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No physiological substrates identified at this stage\",\n        \"Functional consequence of DTX homo-/heterodimerization on substrate selection or E3 activity undefined\",\n        \"In vivo relevance of DTX3 E3 activity not tested\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identification of NOTCH2 and NOTCH4 as direct ubiquitylation substrates established DTX3 as a negative regulator of Notch signaling through receptor degradation, answering whether DTX3 has physiological substrates.\",\n      \"evidence\": \"Yeast two-hybrid screen for DTX3-NOTCH2 interaction, ubiquitination assays, and gain/loss-of-function proliferation assays in esophageal carcinoma cells (NOTCH2); ARE-binding/mRNA stability assays showing DCAF13 controls DTX3 mRNA, plus ubiquitination assays confirming DTX3 targets NOTCH4 for degradation\",\n      \"pmids\": [\"31854042\", \"33300431\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"NOTCH2 and NOTCH4 ubiquitylation studies each from single labs; independent replication lacking\",\n        \"Ubiquitin chain type and specific lysine sites on NOTCH2/NOTCH4 not mapped\",\n        \"Whether DTX3 acts on full-length receptors at the membrane versus cleaved intracellular domain not resolved at this point\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Discovery that DTX3 ubiquitinates mutant p53 to stabilize rather than degrade it revealed context-dependent outcomes of DTX3-mediated ubiquitylation, expanding its substrate repertoire beyond Notch receptors.\",\n      \"evidence\": \"Co-immunoprecipitation and ubiquitination assays in ovarian cancer cells showing DTX3 disrupts MDM2-mutant p53 interaction and stabilizes mutant p53, with in vivo tumor growth validation\",\n      \"pmids\": [\"35782979\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism distinguishing DTX3-mediated stabilizing versus degradative ubiquitylation not elucidated\",\n        \"Ubiquitin chain linkage type on mutant p53 not determined\",\n        \"Single lab; not independently confirmed\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of XRCC5/Ku80 as a DTX3 substrate linked DTX3 to DNA repair protein turnover and AKT signaling suppression, broadening its functional scope beyond Notch.\",\n      \"evidence\": \"IP-mass spectrometry, co-IP, immunofluorescence co-localization in the nucleus, and ubiquitination assays in papillary thyroid carcinoma cells\",\n      \"pmids\": [\"33403043\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether DTX3-mediated XRCC5 ubiquitylation affects DNA repair function not tested\",\n        \"Mechanism linking XRCC5 ubiquitylation to AKT pathway suppression unclear\",\n        \"Single lab with no structural or in vivo validation\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Discovery of the DTX3c isoform and its assembly into a UBA1/UBE2N/Cdc48-p97 complex targeting EphB4 revealed isoform-specific complex formation and a mechanism coupling substrate recruitment to AAA-ATPase unfoldase activity.\",\n      \"evidence\": \"Targeted proteomics and reciprocal co-IP in malignant mesothelioma cells identifying complex members, plus functional perturbation of Cdc48/p97 ATPase activity\",\n      \"pmids\": [\"37108544\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Only one cell system (mesothelioma) tested; generality of the DTX3c complex unknown\",\n        \"Direct in vitro reconstitution of the DTX3c-Cdc48/p97 complex not performed\",\n        \"Ubiquitin chain type on EphB4 and degradation pathway (proteasomal vs. lysosomal) not determined\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstration that DTX3 ubiquitylates DNA and RNA via ester bonds established a fundamentally non-canonical catalytic activity, revealing DTX3 can act on nucleic acid substrates like DTX3L.\",\n      \"evidence\": \"Reconstituted in vitro ubiquitylation assays with purified proteins, ester bond characterization, and DUB reversal by USP2, JOSD1, and SARS-CoV-2 PLpro\",\n      \"pmids\": [\"39242775\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Physiological function of nucleic acid ubiquitylation by DTX3 in cells not demonstrated\",\n        \"Whether DTX3 and DTX3L have redundant or distinct nucleic acid substrates in vivo unknown\",\n        \"Structural basis for DTX3 preference among nucleic acid substrates not resolved\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Mapping the DTX3-NICD interaction to the RING finger domain and demonstrating NICD ubiquitylation/degradation with epistasis via Notch inhibitor DAPT resolved how DTX3 directly suppresses Notch transcriptional output at the level of the active signaling fragment.\",\n      \"evidence\": \"Co-IP with domain truncation mapping, ubiquitination assay, and rescue with DAPT in bladder cancer cells in vitro and in vivo\",\n      \"pmids\": [\"40127622\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether NICD ubiquitylation is the dominant mechanism across all tissue contexts or overlaps with NOTCH2/4 full-length receptor targeting is unresolved\",\n        \"Single lab study; independent confirmation needed\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery that DTX3 monoubiquitylates tankyrase on mono-ADP-ribose (not lysine) introduced a novel non-canonical ubiquitylation modality — a ubiquitin-MAR hybrid mark — that antagonizes PARylation and stabilizes tankyrase by blocking RNF146-dependent degradation. (preprint)\",\n      \"evidence\": \"Cell-based ubiquitylation assays and biochemical characterization of ubiquitin-MAR hybrid mark; identification of RNF114/RNF166 as hybrid-mark readers (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.04.09.648013\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Preprint; not yet peer-reviewed\",\n        \"In vivo significance of the ubiquitin-MAR hybrid mark for Wnt signaling or other tankyrase-dependent pathways not tested\",\n        \"Structural basis for DTX3 recognition of the MAR moiety not determined\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The rules governing whether DTX3 ubiquitylation leads to substrate degradation versus stabilization, and the physiological significance of its nucleic acid and ADP-ribose ubiquitylation activities, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural model of DTX3 or DTX3-substrate complexes exists\",\n        \"Chain-type specificity (K48, K63, mono-Ub) dictating substrate fate not systematically characterized\",\n        \"In vivo mouse knockout or genetic model for DTX3 has not been reported\",\n        \"Relative contributions of canonical protein versus non-canonical nucleic acid/MAR ubiquitylation to DTX3 physiological function unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 2, 3, 4, 5, 6, 8, 9]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0, 1, 2, 3, 4, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005834\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 2, 8]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 2, 3, 4, 6, 8, 9]}\n    ],\n    \"complexes\": [\n      \"DTX homo/heterodimer complex\",\n      \"DTX3c-UBA1-UBE2N-Cdc48/p97 complex\"\n    ],\n    \"partners\": [\n      \"NOTCH2\",\n      \"NOTCH4\",\n      \"XRCC5\",\n      \"UBA1\",\n      \"UBE2N\",\n      \"VCP\",\n      \"EPHB4\",\n      \"TP53\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}